Determination of Quinacrine Dihydrochloride Dihydrate Stability and Characterization of Its Degradants

被引:14
作者
Rotival, Romain [1 ,2 ,3 ]
Espeau, Philippe [1 ]
Corvis, Yohann [1 ]
Guyon, Francois [2 ,3 ]
Do, Bernard [2 ,3 ]
机构
[1] Univ Paris 05, Fac Sci Pharmaceut & Biol, EA 4066, Lab Physicochim Ind Medicament, F-75006 Paris, France
[2] Hop Paris, Etab Pharmaceut, Dept Lab, F-75005 Paris, France
[3] Hop Paris, Etab Pharmaceut, Dept Innovat Pharmaceut, F-75005 Paris, France
关键词
physical stability; chemical stability; dehydration; impurity profiling; thermal analysis; mass spectrometry; GENERALIZED LIPIDOSIS; CHLOROQUINE; DRUGS; CRYSTALLIZATION; OXIDATION; CRYSTAL;
D O I
10.1002/jps.22543
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Although quinacrine dihydrochloride dihydrate is a widely used drug substance, a comprehensive determination of its stability profile is lacking. In this work, an integrative approach is implemented to determine the drug stability both in the solid state and aqueous solutions, identify the impurities that can be found in the active pharmaceutical ingredient, and evaluate the associated toxicity risks. Thermal analyses pointed out a two-step dehydration of the solid state. This phenomenon seems to be consistent with the organization of the water molecules in the crystal structure and results in the destruction of the lattice. Seven related compounds of quinacrine have been identified by liquid chromatography-ion trap mass spectrometry. The main thermal degradant both in the solid state and the solution corresponds to the N-deethyl compound, whereas quinacrine tertiary amine oxyde appears to be a signal impurity of oxidative stress in solution. Moreover, two photolytic impurities can be formed in solution either by aromatic amine cleavage or via O-demethylation. Additionally, using computational approaches, the analysis of the potential toxicity of the impurities compared with the parent compound one shows that ketone and O-demethyl derivatives may exhibit specific toxicity profiles. (C) 2011 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 100:3223-3232, 2011
引用
收藏
页码:3223 / 3232
页数:10
相关论文
共 55 条
[1]   Parallel synthesis of 9-aminoacridines and their evaluation against chloroquine-resistant Plasmodium falciparum [J].
Anderson, MO ;
Sherrill, J ;
Madrid, PB ;
Liou, AP ;
Weisman, JL ;
DeRisi, JL ;
Guy, RK .
BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (02) :334-343
[2]  
[Anonymous], DRUGS PHARM SCI
[3]  
Benigni R, 1998, ENVIRON MOL MUTAGEN, V32, P75, DOI 10.1002/(SICI)1098-2280(1998)32:1<75::AID-EM9>3.0.CO
[4]  
2-A
[5]  
BILAL M, 1995, THERMOCHIM ACTA, V249, P63
[6]  
BODENHEIMER HC, 1983, HEPATOLOGY, V3, P936
[7]   Toward a pharmacophore for drugs inducing the long QT syndrome:: Insights from a CoMFA study of HERG K+ channel blockers [J].
Cavalli, A ;
Poluzzi, E ;
De Ponti, F ;
Recanatini, M .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (18) :3844-3853
[8]   Safety and efficacy of quinacrine in human prion disease (PRION-1 study): a patient-preference trial [J].
Collinge, John ;
Gorham, Michele ;
Hudson, Fleur ;
Kennedy, Angus ;
Keogh, Geraldine ;
Pal, Suvankar ;
Rossor, Martin ;
Rudge, Peter ;
Siddique, Durre ;
Spyer, Moira ;
Thomas, Dafydd ;
Walker, Sarah ;
Webb, Tom ;
Wroe, Steve ;
Darbyshire, Janet .
LANCET NEUROLOGY, 2009, 8 (04) :334-344
[9]   CRYSTAL AND MOLECULAR-STRUCTURE OF QUINACRINE [J].
COURSEIL.C ;
BUSETTA, B ;
HOSPITAL, M .
ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 1973, 29 (NOV15) :2349-2355
[10]  
Cronin M T, 1994, SAR QSAR Environ Res, V2, P159, DOI 10.1080/10629369408029901